|
Molecular properties generated using the CDK |
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes (source: FDA (2003)) |
IUPAC Name ![]() |
| N-{3-[(4-imino-6,7-dimethoxy-3,4-dihydroquinazolin-2-yl)(methyl)amino]propyl}oxolane-2-carboximidic acid |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 5357 | alfuzosin |
Synonyms ![]() |
| SL-77499-10 |
| SL-7749910 |
| Uroxatral® |
Database Links ![]() |
|
| CAS Registry No. | 81403-80-7 |
| ChEMBL Ligand | CHEMBL709 |
| DrugBank Ligand | DB00346 |
| PubChem CID | 2092 |
| Search Google for chemical match using the InChIKey | WNMJYKCGWZFFKR-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | WNMJYKCGWZFFKR |
| Search PubMed clinical trials | alfuzosin |
| Search PubMed titles | alfuzosin |
| Search PubMed titles/abstracts | alfuzosin |
| Wikipedia | Alfuzosin |
| Comments |
| Alfuzosin is an α1-adrenergic receptor antagonist. |